More on ATTO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $14.50 |
|
|||
| Open | $14.00 | ||||
| 52 Wk High | $11.52 | ||||
| 52 Wk Low | $6.77 | ||||
| Day High | $14.75 | ||||
| Day Low | $14.00 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 7,198 | ||||
- Attovia to present pipeline data at two dermatology conferences
- Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026
- Attovia Therapeutics to Participate in Upcoming Investor Conferences
- Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
- Wall Street analysts bullish on Attovia as itch drug data fuel biotech optimism
- Leerink Starts Attovia Therapeutics (ATTO) at Outperform
- LifeSci Capital Starts Attovia Therapeutics (ATTO) at Outperform
- Citi Starts Attovia Therapeutics (ATTO) at Buy
- RBC Capital Starts Attovia Therapeutics (ATTO) at Outperform
- Morgan Stanley Starts Attovia Therapeutics (ATTO) at Overweight
Entities mentioned with ATTO
- Bankruptcy | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- IPO | View Related Stories »
- Morgan Stanley | View Related Stories »
- Credit Suisse | View Related Stories »
- 13D | View Related Stories »
- Bain Capital | View Related Stories »
- Show More...
